The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China por Zongyu Fan, Zongyu Fan, Zongyu Fan, Rongrong Hui, Rongrong Hui, Houyu Ju, Houyu Ju, Houyu Ju, Yunteng Wu, Yunteng Wu, Yunteng Wu, Xuhui Ma, Xuhui Ma, Xuhui Ma, Hao Song, Hao Song, Hao Song, Yang Liu, Yang Liu, Yang Liu, Mengyu Rui, Mengyu Rui, Mengyu Rui, Xinrong Geng, Xinrong Geng, Xinrong Geng, Minqi Zhao, Minqi Zhao, Yingye Xin, Yingye Xin, Dongliang Wei, Dongliang Wei, Dongliang Wei, Guoxin Ren, Guoxin Ren, Guoxin Ren

Ligazón do recurso